Denosumab-associated Periprosthetic Atypical Femur Fracture: A Case Report

INTRODUCTION: Denosumab is generally used for 5–10 years to treat postmenopausal osteoporosis. Although atypical fractures caused by bisphosphonate use are well known, reports of denosumab-associated femur fractures are rare. CASE REPORT: Herein, a 75-year-old woman suffered an atypical periprosthet...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Satomi, Inoue, Masahiro, Mikami, Takashi, Kanno, Taiki, Masuda, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Indian Orthopaedic Research Group 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519314/
https://www.ncbi.nlm.nih.gov/pubmed/37753145
http://dx.doi.org/10.13107/jocr.2023.v13.i09.3864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519314/
https://www.ncbi.nlm.nih.gov/pubmed/37753145
http://dx.doi.org/10.13107/jocr.2023.v13.i09.3864

Ejemplares similares